DF/HCC Prostate SPORE
DF/HCC Prostate SPORE
批准号:
10628271
负责人:
Himisha Beltran
金额:
$24.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-08-31
关键词:
AccelerationAdministratorAdvocateAreaBostonCancer CenterClinical TrialsCollaborationsCommunicationCommunitiesConsentDana-Farber Cancer InstituteDedicationsDevelopmentEducationEducation and OutreachEnrollmentEnsureEnvironmentEthnic PopulationEvaluation ResearchEventFosteringFundingFutureGoalsGrantHuman ResourcesIndividualInfrastructureInstitutionLeadLeadershipLinkMalignant neoplasm of prostateMentorsMentorshipMissionModificationMonitorPatient EducationPatient advocacyPatientsPilot ProjectsProceduresProstateReportingReproduction sporesResearchResearch ActivityResearch PersonnelResource SharingResourcesScheduleScienceScientific Advances and AccomplishmentsTranslational ResearchUnderrepresented PopulationsUpdateWomanWorkanticancer researchcareer developmentdata sharingmeetingsmembermultidisciplinaryoutreachpatient populationprogramsracial populationsocial mediasuccesssymposiumtreatment and outcomeweb site
中文摘要
项目摘要-行政核心(核心a)
英文摘要
PROJECT SUMMARY – ADMINISTRATIVE CORE (CORE A)
The DF/HCC Prostate SPORE Administrative Core (Core A) is instrumental for the overall function and
success of the Prostate SPORE program. The Directors will work closely with Advisory Board Members,
Patient Advocates, and SPORE investigators to foster an environment that promotes collaboration and
transparency in research. Regular reviews and fiscal oversight by Core A will ensure that the program has the
resources it needs to be successful. Core A will also ensure that the SPORE integrates well with the broader
DF/HCC program and is capable of leveraging resources and institutional infrastructure to accelerate
translational prostate cancer research. The Administration Core’s Specific Aims are: 1) to provide resources
and fiscal oversight; 2) to monitor research progress and plan for the future; 3) to integrate the SPORE within
the Dana Farber/Harvard Cancer Center; 4) to foster collaborative research and dissemination of research
findings; and 5) to integrate a patient perspective throughout all research activities in the Prostate SPORE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
"DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"
-
批准号:10681632
-
项目类别:
-
资助金额:$66.29万
-
财政年份:2023
-
负责人:Himisha Beltran
-
依托单位:
Molecular Determinants of Response and Resistance to EZH2 and PARP inhibition in Prostate Cancer
-
批准号:10628273
-
项目类别:
-
资助金额:$47.45万
-
财政年份:2023
-
负责人:Himisha Beltran
-
依托单位:
Career Enhancement Program
-
批准号:10628278
-
项目类别:
-
资助金额:$25.82万
-
财政年份:2023
-
负责人:Himisha Beltran
-
依托单位:
Molecular mechanisms underlying lineage plasticity in prostate cancer
-
批准号:10375455
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2020
-
负责人:Himisha Beltran
-
依托单位:
Molecular mechanisms underlying lineage plasticity in prostate cancer
-
批准号:10596605
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2020
-
负责人:Himisha Beltran
-
依托单位:
Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate Cancer
-
批准号:10227729
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2017
-
负责人:Himisha Beltran
-
依托单位:
Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate Cancer
-
批准号:9357038
-
项目类别:
-
资助金额:$35.19万
-
财政年份:--
-
负责人:Himisha Beltran
-
依托单位:
Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate Cancer
-
批准号:9763525
-
项目类别:
-
资助金额:$34.38万
-
财政年份:--
-
负责人:Himisha Beltran
-
依托单位:
海外基金